Low-Dose Oral Use of Interferon Inhibits Virally Induced Myocarditis
Authors:
- Cassandra M. LawsonCLCassandra M. Lawson
- Manfred W. BeilharzMBManfred W. Beilharz
- 1 August 1999
- journal article
- Published by SAGE Publications in Journal of Interferon & Cytokine Research
- Vol. 19 (8) , 863-867
Abstract
Cytomegalovirus (CMV) infection has been associated with the development of myocarditis in humans. Our established mouse model for CMV myocarditis allows detailed investigation of the immunopathogenic mechanisms and therapies for cardiovascular disease. The type I interferons (IFN-alpha/beta) are part of the innate immune response to CMV infections. Previously, we have reported that daily treatment with low doses of murine IFN-alpha/beta administered by the oral-mucosal route significantly reduces early virus replication of murine CMV in the spleen and liver of infected mice. The oral-mucosal route provides an alternate delivery system to the current modes of IFN administration and is associated with fewer side effects. Since prophylactic treatment with type 1 IFNs may result in both antiviral and immunomodulatory effects that may lessen the development of disease, we wished to study the effect of IFN-alpha/beta on the development of myocarditis. Low-dose oral use of type I IFN (10 IU/day for 7 days prior to virus infection) did not abrogate myocarditis but suppressed the inflammatory response in both the acute and chronic phase of the disease. Furthermore, low-dose oral use of IFN was as effective at inhibiting myocarditis as a single injection of a high dose of IFN (20,000 IU) on the day of virus infection. These findings indicate the need for evaluation of low-dose use of oral IFN in the development of improved clinical therapies for the treatment of cardiovascular disease.Keywords
This publication has 18 references indexed in Scilit:
- Efficacy of Low-Dose Oral Use of Type I Interferon in Cytomegalovirus Infections In VivoJournal of Interferon & Cytokine Research, 1999
- Low-Dose Oral Type I Interferons Reduce Early Virus Replication of Murine Cytomegalovirus In VivoJournal of Interferon & Cytokine Research, 1997
- Mycarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virusJACC, 1994
- Clinical and experimental studies in myocarditisCurrent Opinion in Cardiology, 1994
- Association of cytomegalovirus infection with post‐transplantation cardiac rejection as studied using the polymerase chain reactionJournal of Medical Virology, 1994
- Dilated Cardiomyopathy Caused by Cytomegalovirus Infection in a Renal Transplant Recipient.Japanese Heart Journal, 1992
- Viral MyocarditisClinical Infectious Diseases, 1991
- Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes.Journal of Experimental Medicine, 1989
- Antibody Responses to Murine Cytomegalovirus in Genetically Resistant and Susceptible Strains of MiceJournal of General Virology, 1988
- Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathyThe American Journal of Cardiology, 1983